Literature DB >> 18589438

Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.

Catherine L Day1, Callum Smits, F Cindy Fan, Erinna F Lee, W Douglas Fairlie, Mark G Hinds.   

Abstract

Pro-survival proteins in the B-cell lymphoma-2 (Bcl-2) family have a defined specificity profile for their cell death-inducing BH3-only antagonists. Solution structures of myeloid cell leukaemia-1 (Mcl-1) in complex with the BH3 domains from Noxa and Puma, two proteins regulated by the tumour suppressor p53, show that they bind as amphipathic alpha-helices in the same hydrophobic groove of Mcl-1, using conserved residues for binding. Thermodynamic parameters for the interaction of Noxa, Puma and the related BH3 domains of Bmf, Bim, Bid and Bak with Mcl-1 were determined by calorimetry. These unstructured BH3 domains bind Mcl-1 with affinities that span 3 orders of magnitude, and binding is an enthalpically driven and entropy-enthalpy-compensated process. Alanine scanning analysis of Noxa demonstrated that only a subset of residues is required for interaction with Mcl-1, and these residues are localised to a short highly conserved sequence motif that defines the BH3 domain. Chemical shift mapping of Mcl-1:BH3 complexes showed that Mcl-1 engages all BH3 ligands in a similar way and that, in addition to changes in the immediate vicinity of the binding site, small molecule-wide structural adjustments accommodate ligand binding. Our studies show that unstructured peptides, such as the BH3 domains, behave like their structured counterparts and can bind tightly and selectively in an enthalpically driven process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18589438     DOI: 10.1016/j.jmb.2008.05.071

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  96 in total

1.  Identification of a novel Mcl-1 protein binding motif.

Authors:  William J Placzek; Mattia Sturlese; Bainan Wu; Jason F Cellitti; Jun Wei; Maurizio Pellecchia
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

2.  Heterodimerization of BAK and MCL-1 activated by detergent micelles.

Authors:  Qian Liu; Kalle Gehring
Journal:  J Biol Chem       Date:  2010-10-29       Impact factor: 5.157

3.  Mutation to Bax beyond the BH3 domain disrupts interactions with pro-survival proteins and promotes apoptosis.

Authors:  Peter E Czabotar; Erinna F Lee; Geoff V Thompson; Ahmad Z Wardak; W Douglas Fairlie; Peter M Colman
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

Review 4.  Protein binding specificity versus promiscuity.

Authors:  Gideon Schreiber; Amy E Keating
Journal:  Curr Opin Struct Biol       Date:  2010-11-09       Impact factor: 6.809

5.  BH3-triggered structural reorganization drives the activation of proapoptotic BAX.

Authors:  Evripidis Gavathiotis; Denis E Reyna; Marguerite L Davis; Gregory H Bird; Loren D Walensky
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

6.  Bcl-2 phosphorylation confers resistance on chronic lymphocytic leukaemia cells to the BH3 mimetics ABT-737, ABT-263 and ABT-199 by impeding direct binding.

Authors:  Ting Song; Gaobo Chai; Yubo Liu; Xiaoyan Yu; Ziqian Wang; Zhichao Zhang
Journal:  Br J Pharmacol       Date:  2016-01-16       Impact factor: 8.739

7.  Discovery of marinopyrrole A (maritoclax) as a selective Mcl-1 antagonist that overcomes ABT-737 resistance by binding to and targeting Mcl-1 for proteasomal degradation.

Authors:  Kenichiro Doi; Rongshi Li; Shen-Shu Sung; Hongwei Wu; Yan Liu; Wanda Manieri; Gowdahalli Krishnegowda; Andy Awwad; Alden Dewey; Xin Liu; Shantu Amin; Chunwei Cheng; Yong Qin; Ernst Schonbrunn; Gary Daughdrill; Thomas P Loughran; Said Sebti; Hong-Gang Wang
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

8.  Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas.

Authors:  Elizabeth A Brem; Karen Thudium; Sapna Khubchandani; Ping-Chiao Tsai; Scott H Olejniczak; Seema Bhat; Wasif Riaz; Jenny Gu; Arshad Iqbal; Ryan Campagna; Joy Knight; Cory Mavis; Paul Hoskin; George Deeb; John F Gibbs; Gerald Fetterly; Myron S Czuczman; Francisco J Hernandez-Ilizaliturri
Journal:  Br J Haematol       Date:  2011-04-15       Impact factor: 6.998

Review 9.  Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis.

Authors:  D Westphal; R M Kluck; G Dewson
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

10.  Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes.

Authors:  Emiko Fire; Stefano V Gullá; Robert A Grant; Amy E Keating
Journal:  Protein Sci       Date:  2010-03       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.